Solution
Industries
Resources
About
Beacon Search

Gastrointestinal Pharmaceuticals: Technologies and Markets

Report Code: PHM046B

Publish Date: Sep 2009

Publisher: BCC Publishing

Category: Pharmaceuticals

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • Overall sales in the gastrointestinal disorder treatment market amounted to $34.2 billionin 2007, and decreased slightly to $31.1 billion in 2009. By 2014, they are projected to reach $32.2 billion, for a 5-year compound annual growth rate (CAGR) of 0.7%.
  • The largest segment of the market, prescription gastrointestinal drugs, was valued at $27.4 billion in 2008; this is expected to decrease to $26,3 billion in 2009, and to reach $27 billion in 2014, for a 5-year CAGR of 0.5%.

INTRODUCTION

STUDY GOALS AND OBJECTIVES

The objectives of the study are to present a comprehensive look at disorders of the gastrointestinal system and their respective pharmaceutical treatment options. There are two large general categories of gastrointestinal drugs:

  • Prescription
  • Over-the-counter
Markets are further divided according to type of drug. The report is directed to decision-makers within the gastrointestinal market arena.
 
REASONS FOR DOING THE STUDY
 
This BCC study is presented to heighten the awareness of gastrointestinal disorders and identify pharmaceutical preparations and important advancements in the gastrointestinal markets. The study analyzes therapeutics currently on the market as well as potential products and classes of products that are likely to have a significant impact on the future of both the prescription gastrointestinal drug market and the over-the-counter (OTC) gastrointestinal drug market. Manufacturers of gastrointestinal drug products have stepped up the pace of research and development as the engine driving growth in all markets, especially new treatments for Crohn’s disease and irritable bowel syndrome (IBS). Because of the evolving nature of the many areas of gastrointestinal disorders, executives involved in the specific areas within the gastrointestinal drug market must remain ever vigilant of the changing environment and strive to keep abreast of current and potential opportunities within the gastrointestinal marketplace.
 
INTENDED AUDIENCE
 
The information and analyses presented in this report are important assets in decision-making for managers involved in business development, marketing, market research, product development, mergers and acquisitions, licensing, business management, investment banking and deal creation, and for consultants to the pharmaceutical and biotechnology industry. The study provides a comprehensive analysis of the current markets for gastrointestinal drugs and, in particular, the market potential of technologies in development.
 
SCOPE OF REPORT
 
This report is designed to be a comprehensive business tool to provide an in-depth look at gastrointestinal disorders. The geographic scope of the report is global with a particular emphasis on the United States. Market data is global. The report provides an overview of the gastrointestinal system; gives a brief explanation of disorders of the gastrointestinal system; cites risk factors, where applicable; cites incidence and mortality; presents current pharmaceutical treatments, market size and market participants in both prescription and OTC arenas; and presents potential treatments in research and development, potential market size, and market participants. This report describes the industry in detail, its relationship to the healthcare industry, its participants, and its trends for the future.
 
Within the market for gastrointestinal pharmaceuticals, categories are divided into two general segments:
  • Prescription gastrointestinal pharmaceuticals
  • Over-the-counter gastrointestinal pharmaceuticals
The market is further broken down into the drugs to treat specific disorders within the gastrointestinal system including the following:
  • Gastrointestinal tract disorders
  • Gastrointestinal tract wall disorders
  • Gastrointestinal motility disorders
  • Gastrointestinal malabsorption disorders
  • Gastrointestinal cancers
Each sub segment is addressed in detail, describing disorders and the diseases, identifying current and potential products on the market, and competitors involved in the market.
 
METHODOLOGY AND INFORMATION SOURCES
 
The information and analysis presented in this BCC report are based on extensive firsthand interviews with primary executives, product managers, and clinical specialists in the gastrointestinal pharmaceutical arena. Background information was obtained from various government agencies, business and medical journals, trade magazines, and interviews with doctors and nurses involved in the treatment of gastrointestinal disorders. 
 
Key information from published literature was used to conduct interviews with more than 45 industry participants to validate and obtain expert opinions on current and future trends in the gastrointestinal pharmaceuticals industry. Interviews were the primary basis for development of market size. Interviews were also used to confirm and/or adjust market size and market share estimates, as well as formulating market projections. 
 
All market data pertain to the global market with an emphasis on the U.S. market at the manufacturer’s level. Data are expressed in current U.S. dollars. The base year was 2009. Historical data are provided for 2007 and 2008 and forecast data are provided for 2014. Historical, base year and forecast data are provided for each market segment and sub segment. Market shares are provided for each market segment for the 2009 base year.
 
ANALYST CREDENTIALS
 
Mary Anne Crandall is an expert industry analyst specializing in the pharmaceutical industry for the last 17 years. She has completed several in-depth studies on various medical topics requiring both medical expertise and excellent knowledge of the pharmaceuticals industry. Ms. Crandall has a BS and MS in psychology and is a retired medical instructor. 
 
BCC ONLINE SERVICES
 
Now you can locate the hard-to-find information you need on the Internet. By directing your browser to BCC’s new “home page,” you will be able to:
  • Examine our complete catalog of Market Research Reports and order directly from BCC
  • Subscribe to any of our more than 20 monthly technology/marketing newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well-known conferences
  • Request additional information about any BCC product
  • Take advantage of special offers.
To reach this important new information resource, go to www.bccresearch.com
 
DISCLAIMER
 
This publication provides informative material of a professional nature. It does not constitute managerial, legal, or accounting advice, nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product. This information is intended to be as accurate as possible at the time of publication, but BCC Research assumes no responsibility for any losses or damages that might result because of reliance on this material.
 
Reproduction of any material in this report is strictly forbidden without express permission of the Publisher.
 
To receive a complete catalog of BCC Research studies, please complete the order form at the back of this report or visit our website at www.bccresearch.com.
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
[+] Show Chapter Details
Title/Chapter NamePagesMember Price
Full Report: Gastrointestinal Pharmaceuticals: Technologies and Markets176Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: EXECUTIVE SUMMARY2Free
Chapter- 3: INDUSTRY OVERVIEW43Free
Chapter- 4: PRESCRIPTION PRODUCT SEGMENTS BY TYPE50Free
Chapter- 5: OTC PRODUCT SEGMENTS BY TYPE41Free
Chapter- 6: INDUSTRY PARTICIPANTS BY PRODUCT TYPE 22Free
Chapter- 7: APPENDIX: CONTACT INFORMATION FOR GASTROINTESTINAL MARKET PARTICIPANTS14Free

Related Reports

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 55

  • Summary Table: GLOBAL PRESCRIPTION AND OTC GASTROINTESTINAL DISORDER TREATMENT MARKET, THROUGH 2014
  • Table 1: CAUSES OF DIARRHEA
  • Table 2: COMMON CAUSES OF GASTRITIS
  • Table 3: U.S. ESTIMATED INCIDENCE/PREVALENCE/MORTALITY OF SELECTED GASTROINTESTINAL CONDITIONS
  • Table 4: U.S. POPULATION BY SELECTED AGE GROUPS, 2009 AND 2014
  • Table 5: MARKETED ANTIDIARRHEAL PRODUCTS
  • Table 6: GLOBAL PRESCRIPTION ANTIDIARRHEAL MARKET, BY REGION, THROUGH 2014
  • Table 7: GLOBAL PRESCRIPTION ANTIDIARRHEAL REVENUES AND MARKET SHARE LEVELS, BY MANUFACTURER, 2009
  • Table 8: MARKETED ANTIEMETIC PRODUCTS
  • Table 9: GLOBAL PRESCRIPTION ANTIEMETIC MARKET BY REGION, THROUGH 2014
  • Table 10: GLOBAL PRESCRIPTION ANTIEMETIC REVENUES AND MARKET SHARE BY MANUFACTURER, 2009
Sample Report

Recent Reports

Cardiovascular Drugs: Global Markets to 2030

Published - Apr 2026 | Publisher - BCC Publishing | Code - PHM191B

The global market for cardiovascular drugs was valued at $183.7 billion in 2025 and is estimated to reach $228.6 billion by 2030, at a compound annual growth rate (CAGR) of 4.5% from 2025 through 2030.

Emerging Drugs: Global Markets

Published - Apr 2026 | Publisher - BCC Publishing | Code - PHM291A

The report provides an overview of the global emerging drugs and analyzes market trends, segmented by molecule type, product type, therapeutic application, and end user. It includes global revenue for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The report focuses on trends, challenges, and the competitive landscape, including market share of leading companies and company profiles with financials, product portfolios, and recent developments.

Lung Cancer Therapeutics: Global Markets

Published - Mar 2026 | Publisher - BCC Publishing | Code - PHM206B

The global market for lung cancer therapeutics is expected to grow from $32.5 billion in 2025 and is projected to reach $49.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 8.8% during the forecast period of 2025 to 2030.

Global Bispecific Antibodies Market

Published - Mar 2026 | Publisher - BCC Publishing | Code - PHM290A

This report provides an overview of the global bispecific antibodies market and analyzes market trends. It includes global revenue ($ million) for the base year data for 2022- 2024 and estimated data for the forecast period from 2025 through 2030.

Neuroprotective Agents: Therapeutic Applications and Global Markets

Published - Feb 2026 | Publisher - BCC Publishing | Code - PHM188B

The global market for neuroprotective agents is expected to grow from $43.9 billion in 2025 and is projected to reach $60.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.7% during the forecast period of 2025 to 2030.

Top Trending Reports

Global Markets for Diabetes Therapeutics and Diagnostics

Published - Jan 2026 | Publisher - BCC Publishing | Code - HLC029G

The global market for diabetes therapeutics and diagnostics is estimated to grow from $134.9 billion in 2025 to reach $241.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.4% from 2025 through 2030.

Stem Cell and Regenerative Therapy: Global Markets

Published - Feb 2026 | Publisher - BCC Publishing | Code - BIO191B

The global market for stem cell and regenerative therapy is projected to grow from an estimated $16.7 billion in 2025 to $43.8 billion by 2030, at a compound annual growth rate (CAGR) of 21.3% from 2025 to 2030.

Power Infrastructure for Data Centers: Global Markets

Published - Apr 2026 | Publisher - BCC Publishing | Code - EGY207A

This report provides a comprehensive analysis of global power infrastructure for data centers market, segmented by power infrastructure component, data center type, and end-use. It includes global revenue for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The report focuses on trends, challenges, and the competitive landscape, including market share of leading companies and company profiles with financials, product portfolios, and recent developments.

Data Center Networking Technologies: Global Markets

Published - Dec 2025 | Publisher - BCC Publishing | Code - IFT103C

The global market for data center networking technologies is expected to grow from $45.8 billion in 2025 and is projected to reach $103 billion by the end of 2030, at a compound annual growth rate (CAGR) of 17.6% during the forecast period of 2025 to 2030.

Infusion Pumps and Devices: Technologies and Global Markets

Published - Mar 2026 | Publisher - BCC Publishing | Code - HLC071F

The global market for infusion pumps and devices is expected to grow from $9.7 billion in 2025 and is projected to reach $14.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.9% during the forecast period of 2025 to 2030.

Published - Sep-2005| Analyst - Mary Anne Crandall| Code - PHM046A

Report Highlights

  • The total U.S. market for gastrointestinal disorder treatments was estimated at $16.1 billion for 2004. Rising at an AAGR (average annual growth rate) of 7.3%, the market is expected to reach $22.8 billion in 2009.
  • The prescription market accounted for the largest percentage of sales with approximately 85%, or $13.7 billion in sales in for 2004. This segment is also rising the fastest, with an AAGR of 7.7%.
  • The OTC market accounts for the remaining 15%, or $2.4 billion. Rising at AAGR of 14%, it will represent only 13% of the market in 2009.
  • At approximately 80%, the largest area of market participation for leading competitors is within the prescription drug segment.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Gastrointestinal Pharmaceuticals: Technologies and Markets
Customize This Report
Customize Report
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2025 BCC Research
Privacy Policy |Site Map|Terms & Conditions
AI Sentiment